SCHEMBL27440976

SCHEMBL27440976

CC1CCN(c2cc(OCc3ccccc3)c(Br)c(OCc3ccccc3)c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
ACHE P22303 2/20 0.43
ALDH1A1 P00352 3/20 0.43
HTR6 P50406 2/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MCL1 Q07820 1/20 0.43
SLC6A4 P31645 2/20 0.41
HTR2C P28335 2/20 0.40
MAPK14 Q16539 2/20 0.40
HTR2A P28223 1/20 0.40
HTR2B P41595 1/20 0.40
HTR1A P08908 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27440977 0.83 KDM4E (0.53) KDM4EACHEALDH1A1LMNANPC1
SCHEMBL29998243 0.81 ME3 (0.50) ALDH1A1MEN1MAPTKMT2A
SCHEMBL19381330 0.81 HTR6 (0.50) KDM4EACHEALDH1A1HTR6LMNA
SCHEMBL29105996 0.80 F10 (0.41) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL27440963 0.78 KDM4E (0.40) KDM4EACHEALDH1A1HTR6LMNA
SCHEMBL27451696 0.77 CKS1B (0.50) ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL19381528 0.77 MEN1 (0.48) KDM4EALDH1A1HTR6NPC1RAB9A
SCHEMBL27440966 0.76 KDM4E (0.40) KDM4EACHEALDH1A1HTR6LMNA
SCHEMBL23697934 0.76 KDM4E (0.45) KDM4EACHEALDH1A1LMNANPC1
SCHEMBL27440971 0.75 MAPK1 (0.43) KDM4EALDH1A1LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) 2024-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216357-A1 POLYCYCLIC COMPOUND AND APPLICATION THEREOF KDM1A, TET1, KDM3A KDM4E 40/4885ACHE 2700/4885ALDH1A1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.